Isolithocholic Acid: Properties, Uses & Lab Guidelines
Isolithocholic Acid: Properties, Uses & Lab Guidelines
Isolithocholic acid is a secondary bile acid and stereoisomer of lithocholic acid, generated by gut microbial biotransformation, and is of growing interest in microbiome, hepatology, and metabolic disease research.
- Chemical Name
- Isolithocholic acid (3α-hydroxy-5β-cholan-24-oic acid stereoisomer; specifically 3β-hydroxy-5β-cholan-24-oic acid)
- Compound Class
- Secondary bile acid; monohydroxy bile acid derivative
- Origin
- Produced by gut microbial epimerization of lithocholic acid
- Molecular Formula
- C24H40O3
- Molecular Weight
- Approximately 392.57 g/mol
- Recommended Storage
- Store at -20°C, protected from light and moisture, under inert atmosphere if possible
- Solubility
- Soluble in DMSO, ethanol, and methanol; sparingly soluble in aqueous buffers
Chemical Identity and Structure
Isolithocholic acid (IsoLCA) is a monohydroxy secondary bile acid that is a C-3 epimer of lithocholic acid (LCA). While lithocholic acid carries a 3α-hydroxyl group, isolithocholic acid bears a 3β-hydroxyl configuration on the steroid nucleus, resulting in distinct physicochemical and biological properties despite their nearly identical molecular formulas (C24H40O3; MW ≈ 392.57 g/mol).
The 3β-hydroxyl orientation significantly alters the molecule's amphipathicity and receptor-binding profile relative to its 3α counterpart. This structural difference is critical when designing experiments that aim to discriminate between bile acid stereoisomers or to probe stereospecific biological interactions, such as nuclear receptor binding.
Researchers should verify compound purity (≥95% recommended for biological assays) and confirm stereochemical identity by NMR or HPLC prior to use, as bile acid stereoisomers can co-elute on certain chromatographic systems.
Biological Roles and Research Applications
Isolithocholic acid is generated in the gut through microbial epimerization of lithocholic acid, a process carried out by specific members of the intestinal microbiota. This positions IsoLCA as a key metabolite at the intersection of host bile acid metabolism and gut microbiome activity, making it highly relevant in microbiome research, metabolic syndrome studies, and inflammatory bowel disease (IBD) investigations.
Emerging research suggests that IsoLCA and closely related secondary bile acids may interact with host nuclear receptors — including the farnesoid X receptor (FXR), vitamin D receptor (VDR), and TGR5 — with differing potencies compared to primary bile acids or LCA itself. These interactions can modulate immune cell function, particularly T-regulatory (Treg) cell differentiation, linking gut microbial bile acid metabolism to systemic immune homeostasis.
IsoLCA is also employed as an analytical reference standard in metabolomics and lipidomics workflows, enabling accurate quantification and identification of bile acid profiles in biological matrices such as serum, plasma, feces, and intestinal tissue. It is additionally used in in vitro hepatotoxicity assays, since monohydroxy bile acids at elevated concentrations may exhibit cytotoxic properties.
Handling, Solubilization, and Storage Protocols
Solubilization: Isolithocholic acid is poorly soluble in aqueous media at physiological pH due to its hydrophobic steroid backbone. For stock solution preparation, dissolve in DMSO, absolute ethanol, or methanol at concentrations up to 10–50 mM depending on the solvent. When preparing aqueous working solutions, dilute organic stock solutions stepwise into warm aqueous buffer (pH 7.4) with gentle vortexing. Final DMSO concentration in cell-based assays should not exceed 0.1% (v/v) to avoid solvent cytotoxicity artifacts. For bile acid micelle or vesicle studies, sodium salt forms or alkaline aqueous solutions (pH > 9) may be used to improve solubility.
Storage: Store lyophilized or solid IsoLCA at -20°C in a tightly sealed container, protected from light, heat, and atmospheric moisture. Aliquot stock solutions to avoid repeated freeze-thaw cycles, which may promote epimerization or degradation. Stability under recommended storage conditions is generally acceptable for 12–24 months, though this should be verified per Certificate of Analysis (CoA).
Personal Protective Equipment (PPE): Handle with standard laboratory PPE including nitrile gloves, lab coat, and safety glasses. Avoid inhalation of dust or aerosols when handling powder form. Consult the Safety Data Sheet (SDS) for full hazard information before use.
Quality Control and Analytical Verification
Given the structural similarity between bile acid stereoisomers, rigorous quality control is essential when working with isolithocholic acid. Researchers should request and review the Certificate of Analysis (CoA) for each lot, paying particular attention to purity (≥95% by HPLC), identity confirmation (by NMR, MS, or IR), and water content (Karl Fischer titration).
For quantitative metabolomics or pharmacological studies, preparation of a calibration curve using the same lot as the working standard is recommended. Deuterium-labeled bile acid internal standards (e.g., d4-IsoLCA or structurally related labeled compounds) should be used where available to correct for matrix effects and instrument response variability in LC-MS/MS workflows.
When measuring IsoLCA in biological samples, reverse-phase HPLC or UPLC coupled to triple-quadrupole mass spectrometry (QqQ-MS) with electrospray ionization (ESI) in negative ion mode is the gold-standard analytical approach. Multiple reaction monitoring (MRM) transitions should be validated for the specific instrument and matrix.
Regulatory and Safety Considerations
Isolithocholic acid is supplied as a research-use-only (RUO) reagent and is not approved for diagnostic, therapeutic, or veterinary use. It must not be used in human or animal clinical applications without appropriate regulatory authorization.
Dispose of IsoLCA-containing waste in accordance with your institution's hazardous chemical waste disposal regulations. Organic solvent solutions should be collected separately from aqueous waste streams. Do not dispose of in municipal drains or general waste.
When using IsoLCA in cell culture or animal studies, researchers should comply with all applicable institutional biosafety and animal ethics committee guidelines. Elevated concentrations of monohydroxy bile acids may be hepatotoxic; appropriate dose-range finding studies should precede main experiments.
Frequently asked questions
What is the difference between isolithocholic acid and lithocholic acid?
Isolithocholic acid (IsoLCA) and lithocholic acid (LCA) share the same molecular formula (C24H40O3) but differ in the stereochemistry of the C-3 hydroxyl group: LCA has a 3α-OH configuration, whereas IsoLCA has a 3β-OH configuration. This seemingly minor difference results in altered receptor-binding affinities, amphipathicity, and biological activity, making them functionally distinct despite being structural isomers.
How should I prepare a working solution of isolithocholic acid for cell-based assays?
Prepare a concentrated stock solution (10–50 mM) in DMSO or ethanol, then dilute stepwise into prewarmed cell culture medium or buffer to achieve the desired working concentration. Ensure the final DMSO concentration does not exceed 0.1% (v/v) to prevent solvent-related cytotoxicity. Include a vehicle control (solvent only, matched concentration) in all experiments.
Is isolithocholic acid stable during long-term storage?
Solid IsoLCA stored at -20°C in a sealed, light-protected container is generally stable for up to 12–24 months; however, researchers should refer to the specific Certificate of Analysis (CoA) for lot-specific stability data. Aliquoting stock solutions before freezing minimizes degradation from repeated freeze-thaw cycles. Epimerization back to lithocholic acid is a potential degradation pathway under harsh or acidic conditions.
What analytical method is recommended for detecting isolithocholic acid in biological samples?
Reverse-phase UPLC or HPLC coupled to triple-quadrupole mass spectrometry (LC-MS/MS) in negative electrospray ionization (ESI) mode with multiple reaction monitoring (MRM) is the gold-standard method for sensitive and specific quantification of IsoLCA in complex biological matrices such as serum, plasma, feces, or tissue homogenates. Use a stable isotope-labeled internal standard to control for matrix effects.
References
- Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241-259. doi:10.1194/jlr.R500013-JLR200
- Hang S, Paik D, Yao L, et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature. 2019;576(7785):143-148. doi:10.1038/s41586-019-1785-z
- Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci. 2008;65(16):2461-2483. doi:10.1007/s00018-008-7568-6
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证（带存储）